# Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients

> **NCT02893410** · — · COMPLETED · sponsor: **University Hospital, Brest** · enrollment: 286 (actual)

## Conditions studied

- Polycythemia Vera
- Essential Thrombocythemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02893410
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 286 (ACTUAL)
- **Last updated:** 2018-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02893410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02893410, "Drug Observance and Side Effects of Cytoreductive Drugs in PV and ET Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02893410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*